Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay.

Balter H, Trindade V, Terán M, Gaudiano J, Ferrando R, Paolino A, Rodriguez G, Hermida J, De Marco E, Oliver P.

Curr Radiopharm. 2015 Mar 13. [Epub ahead of print]

PMID:
25771367
2.

Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network.

Steiner JF, Paolino AR, Thompson EE, Larson EB.

EGEMS (Wash DC). 2014 Jun 9;2(2):1067. eCollection 2014.

3.

Accelerating regulatory progress in multi-institutional research.

Paolino AR, Lauf SL, Pieper LE, Rowe J, Vargas IM, Goff MA, Daley MF, Tuzzio L, Steiner JF.

EGEMS (Wash DC). 2014 Jul 10;2(1):1076. doi: 10.13063/2327-9214.1076. eCollection 2014.

4.

Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.

Giglio J, Fernández S, Jentschel C, Pietzsch HJ, Papadopoulos M, Pelecanou M, Pirmettis I, Paolino A, Rey A.

Cancer Biother Radiopharm. 2013 Sep;28(7):541-51. doi: 10.1089/cbr.2012.1440. Epub 2013 May 7.

PMID:
23651043
5.

Biological studies in animal models using [99mTc](CO)3 recombinant annexin V as diagnostic agent of apoptotic processes.

Terán MA, Martínez E, Reyes AL, Paolino A, Vital M, Esperón P, Pacheco JP, Savio E.

Nucl Med Biol. 2011 Feb;38(2):279-85. doi: 10.1016/j.nucmedbio.2010.08.007. Epub 2010 Nov 5.

PMID:
21315284
6.

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.

Sampson JH, Archer GE, Mitchell DA, Heimberger AB, Herndon JE 2nd, Lally-Goss D, McGehee-Norman S, Paolino A, Reardon DA, Friedman AH, Friedman HS, Bigner DD.

Mol Cancer Ther. 2009 Oct;8(10):2773-9. doi: 10.1158/1535-7163.MCT-09-0124.

7.

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Sampson JH, Akabani G, Archer GE, Berger MS, Coleman RE, Friedman AH, Friedman HS, Greer K, Herndon JE 2nd, Kunwar S, McLendon RE, Paolino A, Petry NA, Provenzale JM, Reardon DA, Wong TZ, Zalutsky MR, Pastan I, Bigner DD.

Neuro Oncol. 2008 Jun;10(3):320-9. doi: 10.1215/15228517-2008-012. Epub 2008 Apr 10.

8.

Immunotherapy holds promise for HRPC.

Paolino A.

Lancet Oncol. 2007 Aug;8(8):676. No abstract available.

PMID:
17726784
9.

A protocol for the calibration of gamma cameras to estimate internal contamination in emergency situations.

Dantas BM, Lucena EA, Dantas AL, Araújo F, Rebelo AM, Terán M, Paolino A, Hermida JC, Rojo AM, Puerta JA, Morales J, Bejerano GM, Alfaro M, Ruiz MA, Videla R, Piñones O, González S, Navarro T, Melo D, Cruz-Suárez R.

Radiat Prot Dosimetry. 2007;127(1-4):253-7. Epub 2007 Jun 11.

PMID:
17562649
10.

Circulating VEGF predicts efficacy of cetuximab.

Paolino A.

Lancet Oncol. 2007 May;8(5):379. No abstract available.

PMID:
17514810
11.

Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus.

Sivapalasingam S, Kennedy JS, Borkowsky W, Valentine F, Zhan MX, Pazoles P, Paolino A, Ennis FA, Steigbigel NH.

J Infect Dis. 2007 Apr 15;195(8):1151-9. Epub 2007 Mar 5.

12.

Validity of Chinese herbal medicine called into question.

Paolino A.

Lancet Oncol. 2007 Mar;8(3):196. No abstract available.

PMID:
17354297
13.

Consolidation treatment for ALL-which is best?

Paolino A.

Lancet Oncol. 2007 Feb;8(2):104. No abstract available.

PMID:
17288045
14.

Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology.

Giglio J, Rey A, Cerecetto H, Pirmettis I, Papadopoulos M, León E, Monge A, López de Ceráin A, Azqueta A, González M, Fernández M, Paolino A, León A.

Eur J Med Chem. 2006 Oct;41(10):1144-52. Epub 2006 Jun 19.

PMID:
16782237
15.
16.

Effects of hyperglycemia on neurologic outcome in stroke patients.

Paolino AS, Garner KM.

J Neurosci Nurs. 2005 Jun;37(3):130-5. Review.

PMID:
16001816
17.

188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates.

Savio E, Ures MC, Zeledón P, Trindade V, Paolino A, Mockford V, Malanga A, Fernández M, Gaudiano J.

BMC Nucl Med. 2004 Jan 30;4(1):1.

18.
19.

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.

Sampson JH, Akabani G, Archer GE, Bigner DD, Berger MS, Friedman AH, Friedman HS, Herndon JE 2nd, Kunwar S, Marcus S, McLendon RE, Paolino A, Penne K, Provenzale J, Quinn J, Reardon DA, Rich J, Stenzel T, Tourt-Uhlig S, Wikstrand C, Wong T, Williams R, Yuan F, Zalutsky MR, Pastan I.

J Neurooncol. 2003 Oct;65(1):27-35.

PMID:
14649883
20.

Physico-chemical characterisation and biological evaluation of 188-Rhenium colloids for radiosynovectomy.

Ures M, Savio E, Malanga A, Fernández M, Paolino A, Gaudiano J.

BMC Nucl Med. 2002 Oct 14;2(1):1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk